ES448763A1 - Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento. - Google Patents

Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento.

Info

Publication number
ES448763A1
ES448763A1 ES448763A ES448763A ES448763A1 ES 448763 A1 ES448763 A1 ES 448763A1 ES 448763 A ES448763 A ES 448763A ES 448763 A ES448763 A ES 448763A ES 448763 A1 ES448763 A1 ES 448763A1
Authority
ES
Spain
Prior art keywords
passageway
housing
emptying chamber
placing
interior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES448763A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex Puerto Rico Inc
Original Assignee
Syntex Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Puerto Rico Inc filed Critical Syntex Puerto Rico Inc
Publication of ES448763A1 publication Critical patent/ES448763A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A61M15/0036—Piercing means hollow piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES448763A 1975-06-13 1976-06-10 Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento. Expired ES448763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58677175A 1975-06-13 1975-06-13

Publications (1)

Publication Number Publication Date
ES448763A1 true ES448763A1 (es) 1977-12-16

Family

ID=24347051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES448763A Expired ES448763A1 (es) 1975-06-13 1976-06-10 Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento.

Country Status (7)

Country Link
US (2) US4105027A (es)
CA (1) CA1054479A (es)
DE (1) DE2625925A1 (es)
ES (1) ES448763A1 (es)
FR (1) FR2313946A1 (es)
GB (1) GB1521000A (es)
ZA (1) ZA763490B (es)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE46865B1 (en) * 1977-04-29 1983-10-19 Allen & Hanburys Ltd Device for dispensing medicaments
FR2431328A1 (fr) * 1978-07-19 1980-02-15 Inst Nat Radio Elements Dispositif de distribution de gaz radioactif
US4227522A (en) * 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
DE3050005A1 (de) * 1979-10-30 1982-03-18 Riker Laboratories Inc Breath actuated devices for administering powdered medicaments
US4307734A (en) * 1980-06-23 1981-12-29 B & B Inventors & Marketers, Inc. Snuff dispenser
ES506585A0 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS63143081A (ja) * 1986-12-05 1988-06-15 メクト株式会社 吸入器
IT1228460B (it) * 1989-02-23 1991-06-19 Phidea S R L Inalatore monouso con capsula pre-forata
IT1237118B (it) * 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
GB9012870D0 (en) * 1990-06-08 1990-08-01 Glaxo Group Ltd Device
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
JP3230056B2 (ja) * 1991-07-02 2001-11-19 インヘイル・インコーポレーテッド 薬剤のエーロゾル化服用量を形成する装置
US5337740A (en) * 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
DE4239402A1 (de) * 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
AU684754B2 (en) * 1993-03-03 1998-01-08 Glaxo Wellcome Inc. Dry powder inhalator medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
JP3388896B2 (ja) * 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
NZ293163A (en) 1994-09-21 1998-09-24 Inhale Therapeutic Syst Inhalation medicament disperser, aerosol from high pressure gas entrainment of fluidised powder drawn from receptacle feed tube
US20040237961A1 (en) * 1995-06-08 2004-12-02 Snow John Medlin Inhalation actuated device for use with metered dose inhalers (MDIs)
US6672304B1 (en) 1995-06-08 2004-01-06 Innovative Devices, Llc Inhalation actuated device for use with metered dose inhalers (MDIs)
US6209538B1 (en) * 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
SE9502800D0 (sv) * 1995-08-10 1995-08-10 Astra Ab Disposable inhaler
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
AU720813B2 (en) * 1996-04-25 2000-06-15 Astrazeneca Ab Inhaler
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US6257233B1 (en) * 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US6234169B1 (en) * 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
US6382208B2 (en) 1998-11-02 2002-05-07 Board Of Regents University Of Nebraska System for controlling the internal temperature of a respirator
US6418936B1 (en) * 1999-05-14 2002-07-16 Sandia Corp. Tobacco pipe
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
GB2364919A (en) * 2000-07-21 2002-02-13 Cambridge Consultants Inhalers
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
DE60101451T2 (de) * 2001-03-05 2004-10-21 Pera Ivo E Inhaliergerät zur Verteilung von in einer Kapsel enthaltenen Medikamenten in Pulverform durch die Atemwege
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
GEP20074268B (en) * 2001-06-15 2007-12-25 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary administration
AU2003220222A1 (en) 2002-03-13 2003-09-29 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
ITMO20020297A1 (it) * 2002-10-16 2004-04-17 Roberto Oliva Inalatore per preparati monodose in capsule.
NZ540936A (en) * 2002-12-13 2007-01-26 Otsuka Pharma Co Ltd Inhalation device for transpulmonary administration
US7722566B2 (en) * 2003-10-09 2010-05-25 Shin Nippon Biomedical Laboratories, Ltd. Device to deliver a powdery medicine into nasal cavity
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
CA2563365A1 (en) * 2004-04-23 2005-11-03 Mystic Pharmaceuticals, Inc. Multiple unit dose drug delivery system
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
CA2601777A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US9345745B2 (en) * 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
WO2007052154A2 (en) 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
US8763605B2 (en) 2005-07-20 2014-07-01 Manta Devices, Llc Inhalation device
CA2620123C (en) * 2005-08-24 2011-11-22 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
BRPI0806474A2 (pt) 2007-01-09 2011-09-27 Mystic Pharmaceuticals Inc dispositivos de cartucho intranasal
DK2617431T3 (en) * 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and applications therefor
US7669597B2 (en) 2007-05-16 2010-03-02 Mystic Pharmaceuticals, Inc. Combination unit dose dispensing containers
US9248076B2 (en) 2007-05-16 2016-02-02 Mystic Pharmaceuticals, Inc. Dose dispensing containers
US8683995B2 (en) 2007-05-16 2014-04-01 Mystic Pharmaceuticals, Inc. Dose dispensing containers
WO2008156586A2 (en) * 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
US11224704B2 (en) 2007-07-06 2022-01-18 Manta Devices, Llc Dose delivery device for inhalation
EP2898914B1 (en) * 2007-07-06 2018-06-20 Manta Devices, LLC Inhalation devices for storing and delivering medicament
WO2009021137A2 (en) * 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
WO2009036422A1 (en) * 2007-09-14 2009-03-19 Mystic Pharmaceuticals, Inc. Deep draw container forming method
EP2224983B1 (en) 2007-12-20 2017-05-10 AstraZeneca AB Device and method for deaggregating powder 854
EP2082763A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhaler
EP2326339A4 (en) * 2008-05-21 2012-06-20 Neurotez Inc METHOD FOR TREATING PROGRESSIVE COGNITIVE DISORDER IN CONNECTION WITH NEUROFIBRILLARY TANGLES
KR20170001756A (ko) * 2008-10-20 2017-01-04 모레 매트릭스 인코포레이티드 유착 치료 또는 예방용 폴리펩티드
EP2352510A4 (en) * 2008-11-04 2012-08-29 Neurotez Inc LEPTIN COMPOSITIONS AND METHODS OF TREATING PROGRESSIVE COGNITIVE DISORDERS DUE TO THE ASSEMBLY OF NEUROFIBRILLARY BUNNELS AND AMYLOID BETA
AT507631B1 (de) * 2008-11-26 2012-05-15 Haas Rouven Mag Vorrichtung zum ansaugen von pulver- oder granulat-material und kapsel hierfür
US9327008B2 (en) * 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
BRPI1015579A2 (pt) 2009-07-01 2019-09-24 Astrazeneca Ab distribuidor e método para suspender pó em um fluxo de ar
SG10201500620PA (en) 2009-07-24 2015-03-30 Amazentis Sa Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
JP6031510B2 (ja) 2011-04-12 2016-11-24 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US9579337B2 (en) 2011-04-25 2017-02-28 Cornell University Use of uridine and deoxyuridine to treat folate-responsive pathologies
EP2589381B1 (en) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions for improving or preserving lung function in a patient with a pulmonary disorder
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2014039533A2 (en) 2012-09-04 2014-03-13 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
SG11201601850YA (en) 2013-09-10 2016-04-28 Univ Texas Therapeutics targeting truncated adenomatous polyposis coli (apc) proteins
NO2709641T3 (es) * 2014-03-10 2018-05-12
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
US11147936B2 (en) 2014-05-02 2021-10-19 Manta Devices, Llc Dose delivery device with cover connected to dose chamber seal
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
SG11201703939XA (en) 2014-11-17 2017-06-29 Moerae Matrix Inc Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
AU2015359043C1 (en) 2014-12-10 2022-01-06 Hyperstem, SA Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brian tumors
AU2016205125A1 (en) 2015-01-08 2017-07-13 Moerae Matrix, Inc. Formulation of MK2 inhibitor peptides
US9999655B2 (en) 2015-03-12 2018-06-19 Moerae Matrix, Inc. Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
US9937154B2 (en) 2015-06-10 2018-04-10 Hackensak University Medical Center Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
WO2017007634A1 (en) 2015-07-06 2017-01-12 The Board Of Regents Of The University Of Texas System Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
WO2017011215A1 (en) 2015-07-15 2017-01-19 The Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
CA3008996A1 (en) * 2015-12-24 2017-06-29 Philip Morris Products S.A. Nicotine particle capsule
AU2017210319A1 (en) 2016-01-20 2018-08-23 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
US11260184B2 (en) * 2016-11-30 2022-03-01 Philip Morris Products S.A. Inhaler with sized cavity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1406903A (en) * 1919-10-23 1922-02-14 William H Rose Dry-spray gun
US1406904A (en) * 1921-10-21 1922-02-14 William H Rose Dry-spray gun
US1870558A (en) * 1928-06-22 1932-08-09 Adela N Darby Device for treating nasal and pulmonary afflictions
US2244071A (en) * 1940-02-27 1941-06-03 Paul E Landrus Collapsible tube
GB627662A (en) * 1947-07-03 1949-08-12 Metal Box Co Ltd Improvements in or relating to containers for inhalants
US2478715A (en) * 1948-07-14 1949-08-09 Vilbiss Co Powder blower
US2592369A (en) * 1948-10-15 1952-04-08 Abbott Lab Powder inhaler
US2549303A (en) * 1949-04-20 1951-04-17 Bristol Lab Inc Inhaler for crystalline pencilllin or the like
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
US2659517A (en) * 1951-09-21 1953-11-17 Jr Carl H Reinhardt Paste type products container and dispenser therefor having a cutter-valve for opening the container
US3039463A (en) * 1960-05-09 1962-06-19 Jr James W Dickey Gastric suction control device
US3119561A (en) * 1961-08-14 1964-01-28 Midland Pharmaceuticals Inc Medicine dispenser
US3375828A (en) * 1965-04-15 1968-04-02 Brunswick Corp Suction catheter
FR2224175B1 (es) * 1973-04-04 1978-04-14 Isf Spa
US3885607A (en) * 1973-11-16 1975-05-27 Richard I Peltier Device for providing fluid communication between two sealed vessels

Also Published As

Publication number Publication date
FR2313946A1 (fr) 1977-01-07
US4064878A (en) 1977-12-27
DE2625925A1 (de) 1976-12-23
GB1521000A (en) 1978-08-09
CA1054479A (en) 1979-05-15
FR2313946B1 (es) 1978-05-19
US4105027A (en) 1978-08-08
ZA763490B (en) 1978-01-25

Similar Documents

Publication Publication Date Title
ES448763A1 (es) Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento.
ES444239A1 (es) Un dispositivo para inhalacion destinado a administrar un medicamento desde un recipiente que lo contiene.
ES444241A1 (es) Un dispositivo de inhalacion que actua con la respiracion para administrar un medicamento a partir de un envase conte-nedor del mismo.
ES245396U (es) Dispositivo de inhalacion perfeccionado
ES444240A1 (es) Un dispositivo para administrar un medicamento en polvo por inhalacion de un usuario.
ES8600947A1 (es) Dispositivo de administracion para uso medico
ES245395U (es) Dispositivo de inhalacion con abridor de capsula
ES444238A1 (es) Un dispositivo de inhalacion.
HU9201956D0 (en) Medicine eliminating apparatus
GB1526303A (en) Device for the inhalation of medicaments
ES428490A1 (es) Perfeccionamientos en dispositivos aplicadores para medica-mentos en polvo.
GB1305172A (es)
ES252912U (es) Aparato para la inhalacion de medicamentos
GB952656A (en) Improvements in or relating to medicament administering apparatus
PT79522A (en) Medical administration devices